200 related articles for article (PubMed ID: 25617592)
1. The lipid peroxidation product 4-hydroxy-trans-2-nonenal causes protein synthesis in cardiac myocytes via activated mTORC1-p70S6K-RPS6 signaling.
Calamaras TD; Lee C; Lan F; Ido Y; Siwik DA; Colucci WS
Free Radic Biol Med; 2015 May; 82():137-46. PubMed ID: 25617592
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.
Dolinsky VW; Chan AY; Robillard Frayne I; Light PE; Des Rosiers C; Dyck JR
Circulation; 2009 Mar; 119(12):1643-52. PubMed ID: 19289642
[TBL] [Abstract][Full Text] [Related]
3. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.
Kang S; Chemaly ER; Hajjar RJ; Lebeche D
J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152
[TBL] [Abstract][Full Text] [Related]
4. Stimulatory effect of insulin on theca-interstitial cell proliferation and cell cycle regulatory proteins through MTORC1 dependent pathway.
Palaniappan M; Menon B; Menon KM
Mol Cell Endocrinol; 2013 Feb; 366(1):81-9. PubMed ID: 23261705
[TBL] [Abstract][Full Text] [Related]
5. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
Han S; Khuri FR; Roman J
Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake.
Ginion A; Auquier J; Benton CR; Mouton C; Vanoverschelde JL; Hue L; Horman S; Beauloye C; Bertrand L
Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H469-77. PubMed ID: 21602475
[TBL] [Abstract][Full Text] [Related]
7. Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte.
Chan AY; Soltys CL; Young ME; Proud CG; Dyck JR
J Biol Chem; 2004 Jul; 279(31):32771-9. PubMed ID: 15159410
[TBL] [Abstract][Full Text] [Related]
8. Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction.
Ikeda Y; Sato K; Pimentel DR; Sam F; Shaw RJ; Dyck JR; Walsh K
J Biol Chem; 2009 Dec; 284(51):35839-49. PubMed ID: 19828446
[TBL] [Abstract][Full Text] [Related]
9. Herbal supplement Kamishimotsuto augments resistance exercise-induced mTORC1 signaling in rat skeletal muscle.
Kido K; Sato K; Makanae Y; Ato S; Hayashi T; Fujita S
Nutrition; 2016 Jan; 32(1):108-13. PubMed ID: 26423232
[TBL] [Abstract][Full Text] [Related]
10. Two widely used RSK inhibitors, BI-D1870 and SL0101, alter mTORC1 signaling in a RSK-independent manner.
Roffé M; Lupinacci FC; Soares LC; Hajj GN; Martins VR
Cell Signal; 2015 Aug; 27(8):1630-42. PubMed ID: 25889895
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating AMP-activated protein kinase in renal epithelial cells.
Lee HJ; Mariappan MM; Feliers D; Cavaglieri RC; Sataranatarajan K; Abboud HE; Choudhury GG; Kasinath BS
J Biol Chem; 2012 Feb; 287(7):4451-61. PubMed ID: 22158625
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of ribosomal protein S6 mediates compensatory renal hypertrophy.
Xu J; Chen J; Dong Z; Meyuhas O; Chen JK
Kidney Int; 2015 Mar; 87(3):543-56. PubMed ID: 25229342
[TBL] [Abstract][Full Text] [Related]
13. Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase.
Kimball SR; Siegfried BA; Jefferson LS
J Biol Chem; 2004 Dec; 279(52):54103-9. PubMed ID: 15494402
[TBL] [Abstract][Full Text] [Related]
14. Testosterone induces cardiomyocyte hypertrophy through mammalian target of rapamycin complex 1 pathway.
Altamirano F; Oyarce C; Silva P; Toyos M; Wilson C; Lavandero S; Uhlén P; Estrada M
J Endocrinol; 2009 Aug; 202(2):299-307. PubMed ID: 19474060
[TBL] [Abstract][Full Text] [Related]
15. Post-translational modification of serine/threonine kinase LKB1 via Adduction of the Reactive Lipid Species 4-Hydroxy-trans-2-nonenal (HNE) at lysine residue 97 directly inhibits kinase activity.
Calamaras TD; Lee C; Lan F; Ido Y; Siwik DA; Colucci WS
J Biol Chem; 2012 Dec; 287(50):42400-6. PubMed ID: 23086944
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy.
Sadoshima J; Izumo S
Circ Res; 1995 Dec; 77(6):1040-52. PubMed ID: 7586215
[TBL] [Abstract][Full Text] [Related]
17. 4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice.
Wang C; Cigliano A; Jiang L; Li X; Fan B; Pilo MG; Liu Y; Gui B; Sini M; Smith JW; Dombrowski F; Calvisi DF; Evert M; Chen X
Hepatology; 2015 Jan; 61(1):200-13. PubMed ID: 25145583
[TBL] [Abstract][Full Text] [Related]
18. Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR/p70S6K signaling and promoting autophagy.
Zheng RH; Zhang WW; Ji YN; Bai XJ; Yan CP; Wang J; Bai F; Zhao ZQ
Eur J Pharmacol; 2020 Sep; 883():173318. PubMed ID: 32621911
[TBL] [Abstract][Full Text] [Related]
19. mTORC1 inhibition increases neurotensin secretion and gene expression through activation of the MEK/ERK/c-Jun pathway in the human endocrine cell line BON.
Li J; Liu J; Song J; Wang X; Weiss HL; Townsend CM; Gao T; Evers BM
Am J Physiol Cell Physiol; 2011 Jul; 301(1):C213-26. PubMed ID: 21508335
[TBL] [Abstract][Full Text] [Related]
20. Retinoid X receptor agonists inhibit hypertension-induced myocardial hypertrophy by modulating LKB1/AMPK/p70S6K signaling pathway.
Zhu J; Ning RB; Lin XY; Chai DJ; Xu CS; Xie H; Zeng JZ; Lin JX
Am J Hypertens; 2014 Aug; 27(8):1112-24. PubMed ID: 24603314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
